1-12 of 12
Yong Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Chemoradiotherapy and Subsequent Immunochemotherapy as Conversion Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase II NEXUS-1 Trial

Xin Wang, Xiaozheng Kang, Ruixiang Zhang, Liyan Xue, Jiaqi Xu, Xiaotian Zhao, Qiuxiang Ou, Nuo Yu, Guojie Feng, Jiao Li, Ziyu Zheng, Xiankai Chen, Zhen Wang, Qingfeng Zheng, Yong Li, Jianjun Qin, Nan Bi, Yin Li
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (22): 5061–5072.
https://doi.org/10.1158/1078-0432.CCR-24-1236
Published: 15 November 2024
View article titled, Chemoradiotherapy and Subsequent Immunochemotherapy as Conversion Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase II NEXUS-1 Trial
Open the PDF for Chemoradiotherapy and Subsequent Immunochemotherapy as Conversion Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase II NEXUS-1 Trial in another window
Includes: Supplementary data
Journal Articles

Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL

Zijun Y. Xu-Monette, Yong Li, Thomas Snyder, Tiantian Yu, Tingxun Lu, Alexandar Tzankov, Carlo Visco, Govind Bhagat, Wenbin Qian, Karen Dybkaer, April Chiu, Wayne Tam, Youli Zu, Eric D. Hsi, Fredrick B. Hagemeister, Yingjun Wang, Heounjeong Go, Maurilio Ponzoni, Andrés J.M. Ferreri, Michael B. Møller, Benjamin M. Parsons, Xiangshan Fan, J. Han van Krieken, Miguel A. Piris, Jane N. Winter, Qingyan Au, Ilan Kirsch, Mingzhi Zhang, John Shaughnessy, Bing Xu, Ken H. Young
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (23): 4808–4821.
https://doi.org/10.1158/1078-0432.CCR-23-1554
Published: 01 December 2023
View article titled, Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL
Open the PDF for Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL in another window
Includes: Supplementary data
Journal Articles

Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations

Michael J. Grant, Jacqueline V. Aredo, Jacqueline H. Starrett, Paul Stockhammer, Iris K. van Alderwerelt van Rosenburgh, Anna Wurtz, Andrew J. Piper-Valillo, Zofia Piotrowska, Christina Falcon, Helena A. Yu, Charu Aggarwal, Dylan Scholes, Tejas Patil, Christina Nguyen, Manali Phadke, Fang-Yong Li, Joel Neal, Mark A. Lemmon, Zenta Walther, Katerina Politi, Sarah B. Goldberg
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (11): 2123–2130.
https://doi.org/10.1158/1078-0432.CCR-22-3497
Published: 01 June 2023
View article titled, Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations
Open the PDF for Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations in another window
Includes: Supplementary data
Journal Articles

Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma

Zijun Y. Xu-Monette, Li Wei, Xiaosheng Fang, Qingyan Au, Harry Nunns, Máté Nagy, Alexandar Tzankov, Feng Zhu, Carlo Visco, Govind Bhagat, Karen Dybkaer, April Chiu, Wayne Tam, Youli Zu, Eric D. Hsi, Fredrick B. Hagemeister, Xiaoping Sun, Xin Han, Heounjeong Go, Maurilio Ponzoni, Andrés J.M. Ferreri, Michael B. Møller, Benjamin M. Parsons, J. Han van Krieken, Miguel A. Piris, Jane N. Winter, Yong Li, Bing Xu, Maher Albitar, Hua You, Ken H. Young
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (5): 972–983.
https://doi.org/10.1158/1078-0432.CCR-21-2949
Published: 03 March 2022
View article titled, Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma
Open the PDF for Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma

Yue Chen, Zhi-Yong Li, Guan-Qun Zhou, Ying Sun
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (1): 330–341.
https://doi.org/10.1158/1078-0432.CCR-20-2166
Published: 04 January 2021
View article titled, An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma
Open the PDF for An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract NT-101: QUADRA: A PHASE 2, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE SINGLE-AGENT NIRAPARIB TREATMENT IN PATIENTS WITH RELAPSED OVARIAN CANCER (ROC) WHO HAVE RECEIVED ≥3 PRIOR CHEMOTHERAPY REGIMENS

Kathleen Moore, Angeles Secord, Melissa Geller, David Miller, Noelle Cloven, Gini Fleming, Andrea E. Wahner Hendrickson, Masoud Azodi, Paul Disilvestro, Amit Oza, Mihaela Cristea, Jonathan S. Berek, John Chan, Yong Li, Kaiming Sun, Katarina Luptakova, Ursula A. Matulonis, Bradley J. Monk
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (22_Supplement): NT-101.
https://doi.org/10.1158/1557-3265.OVCASYMP18-NT-101
Published: 15 November 2019
View article titled, Abstract NT-101: QUADRA: A PHASE 2, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE SINGLE-AGENT NIRAPARIB TREATMENT IN PATIENTS WITH RELAPSED OVARIAN CANCER (ROC) WHO HAVE RECEIVED ≥3 PRIOR CHEMOTHERAPY REGIMENS
Journal Articles

A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer

Shaoxu Wu, Junjiong Zheng, Yong Li, Hao Yu, Siya Shi, Weibin Xie, Hao Liu, Yangfan Su, Jian Huang, Tianxin Lin
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (22): 6904–6911.
https://doi.org/10.1158/1078-0432.CCR-17-1510
Published: 14 November 2017
View article titled, A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer
Open the PDF for A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer in another window
Includes: Supplementary data
Journal Articles

Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma

Zijun Y. Xu-Monette, Qipan Deng, Ganiraju C. Manyam, Alexander Tzankov, Ling Li, Yi Xia, Xiao-xiao Wang, Dehui Zou, Carlo Visco, Karen Dybkær, Jun Li, Li Zhang, Han Liang, Santiago Montes-Moreno, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L. Richards, Eric D. Hsi, William W.L. Choi, J. Han van Krieken, Jooryung Huh, Maurilio Ponzoni, Andrés J.M. Ferreri, Ben M. Parsons, Michael B. Møller, Sa A. Wang, Roberto N. Miranda, Miguel A. Piris, Jane N. Winter, L. Jeffrey Medeiros, Yong Li, Ken H. Young
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (14): 3593–3605.
https://doi.org/10.1158/1078-0432.CCR-15-2296
Published: 14 July 2016
View article titled, Clinical and Biologic Significance of <em>MYC</em> Genetic Mutations in <em>De Novo</em> Diffuse Large B-cell Lymphoma
Open the PDF for Clinical and Biologic Significance of <em>MYC</em> Genetic Mutations in <em>De Novo</em> Diffuse Large B-cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

Metabolite biomarkers of prostate cancer

Danny Alexander, Arul Chinnaiyan, Arun Sreekumar, Alvin Berger, Matthew Mitchell, Costel Chirilla, Klaus-Peter Adam, Robert Lonigro, Laila Poisson, Yong Li, Javed Siddiqui, John Wei, Jeffrey Shuster
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (19_Supplement): A27.
Published: 15 August 2014
View article titled, Metabolite biomarkers of prostate cancer
Journal Articles

Inhibition of Micrometastatic Prostate Cancer Cell Spread in Animal Models By 213Bilabeled Multiple Targeted α Radioimmunoconjugates

Yong Li, Emma Song, Syed M. Abbas Rizvi, Carl A. Power, Julia Beretov, Chand Raja, Paul J. Cozzi, Alfred Morgenstern, Christos Apostolidis, Barry J. Allen, Pamela J. Russell
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (3): 865–875.
https://doi.org/10.1158/1078-0432.CCR-08-1203
Published: 02 February 2009
View article titled, Inhibition of Micrometastatic Prostate Cancer Cell Spread in Animal Models By <sup>213</sup>Bilabeled Multiple Targeted α Radioimmunoconjugates
Open the PDF for Inhibition of Micrometastatic Prostate Cancer Cell Spread in Animal Models By <sup>213</sup>Bilabeled Multiple Targeted α Radioimmunoconjugates in another window
Journal Articles

Characterization of Genetically Modified T-Cell Receptors that Recognize the CEA:691-699 Peptide in the Context of HLA-A2.1 on Human Colorectal Cancer Cells

Maria R. Parkhurst, Jayne Joo, John P. Riley, Zhiya Yu, Yong Li, Paul F. Robbins, Steven A. Rosenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (1): 169–180.
https://doi.org/10.1158/1078-0432.CCR-08-1638
Published: 31 December 2008
View article titled, Characterization of Genetically Modified T-Cell Receptors that Recognize the CEA:691-699 Peptide in the Context of HLA-A2.1 on Human Colorectal Cancer Cells
Open the PDF for Characterization of Genetically Modified T-Cell Receptors that Recognize the CEA:691-699 Peptide in the Context of HLA-A2.1 on Human Colorectal Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Immunization of Patients with the hTERT:540-548 Peptide Induces Peptide-Reactive T Lymphocytes That Do Not Recognize Tumors Endogenously Expressing Telomerase

Maria R. Parkhurst, John P. Riley, Takehito Igarashi, Yong Li, Paul F. Robbins, Steven A. Rosenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (14): 4688–4698.
https://doi.org/10.1158/1078-0432.CCR-04-0325
Published: 21 July 2004
View article titled, Immunization of Patients with the hTERT:540-548 Peptide Induces Peptide-Reactive T Lymphocytes That Do Not Recognize Tumors Endogenously Expressing Telomerase
Open the PDF for Immunization of Patients with the hTERT:540-548 Peptide Induces Peptide-Reactive T Lymphocytes That Do Not Recognize Tumors Endogenously Expressing Telomerase in another window